Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: Clinical considerations
- 1 September 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (14) , 2296-2302
- https://doi.org/10.1016/j.ejca.2006.03.025
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Current Concepts of Treatment Strategies in Advanced or Recurrent Ovarian CancerOncology, 2005
- Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) studyAnnals of Oncology, 2005
- The role of secondary cytoreductive surgery for recurrent ovarian cancerPublished by Elsevier ,2005
- Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridizationInternational Journal of Gynecologic Cancer, 2005
- Duration of Response to Second-Line, Platinum-Based Chemotherapy for Ovarian Cancer: Implications for Patient Management and Clinical Trial DesignJournal of Clinical Oncology, 2004
- Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel: The Memorial Sloan-Kettering Cancer Center experienceGynecologic Oncology, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Part II: Chemotherapy for epithelial ovarian cancer-treatment of rcurrent diseaseThe Lancet Oncology, 2002
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958